Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001759138-26-000011
Filing Date
2026-03-23
Accepted
2026-03-23 07:36:12
Documents
84
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K caba-20251231.htm   iXBRL 10-K 3394946
2 EX-4.2 caba-ex4_2.htm EX-4.2 56100
3 EX-10.8 caba-ex10_8.htm EX-10.8 114117
4 EX-10.38 caba-ex10_38.htm EX-10.38 346200
5 EX-21.1 caba-ex21_1.htm EX-21.1 6920
6 EX-23.1 caba-ex23_1.htm EX-23.1 12351
7 EX-31.1 caba-ex31_1.htm EX-31.1 16426
8 EX-31.2 caba-ex31_2.htm EX-31.2 16529
9 EX-32.1 caba-ex32_1.htm EX-32.1 10345
10 EX-32.2 caba-ex32_2.htm EX-32.2 10339
11 GRAPHIC img117331299_0.jpg GRAPHIC 159052
12 GRAPHIC img117331299_1.gif GRAPHIC 325735
13 GRAPHIC img117331299_2.jpg GRAPHIC 659219
14 GRAPHIC img267305973_0.jpg GRAPHIC 12421
  Complete submission text file 0001759138-26-000011.txt   14952232

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20251231.xsd EX-101.SCH 1447384
88 EXTRACTED XBRL INSTANCE DOCUMENT caba-20251231_htm.xml XML 1818880
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39103 | Film No.: 26779910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)